Christophe F. Grosset

Strategic Lead - Marketscreener Italy

Because finance isn’t just about numbers, Christophe F. Grosset explores the ideas, trends and people reshaping it. Between Milan and Geneva, he highlights innovation, markets, and those reinventing the industry. Follow him on MarketScreener Italia — where finance meets curiosity.

UCB raises guidance on strength of its two flagship treatments, analysts applaud

Supported by sustained commercial momentum, the Belgian biopharmaceutical group (+13.05%, at EUR240.20) announced another increase in its financial targets for FY 2026. Strong revenue growth is generating significant operating leverage, allowing for a marked expansion in margins.

October 22, 2026 at 02:35 pm IST

UCB

Discover our authors

Chief Editor

Analyst

Analyst Apprentice

Junior Analyst

Journalist

Latest analyses

	Surging oil prices drag Indian shares to weekly losses
	European markets weaker after PMIs; Eni results provide a boost
	India's Swiggy falls to record low as quick-commerce losses widen
	VanEck analysis: a more mature gold sector focused on profitability and execution
	India's September crude oil imports jump over 16% month-on-month
	India October business growth hits 4-month high; hiring stalls, PMI shows
	Euro sinks on French debt worries, yen gains for week on AI rout
	Inspired Capital Closes New $450 Million Fund
	US to remove 50% tariffs on some Canadian goods to help Republicans in midterms, WSJ reports
	Mark Cuban says AI hack agents are like cockroaches, but can be controlled

All Analysis